Skip to content

The effectiveness of a novel osseous densification approach on implants' primary and secondary stability: a clinical trial

The effectiveness of osseodensification drilling versus conventional surgical technique on implant stability: a clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN15797074
Enrollment
120
Registered
2024-04-02
Start date
2019-02-06
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental implant stability in low density bone Oral Health

Interventions

Osseodensification and conventional drilling in dental implant surgery in type IV bone. All patients underwent a preliminary assessment that included a careful analysis of their medical and dental hi
ii) 6 months after implant placement (T2)
iii) 1-year follow-up (T3).

Sponsors

Infante da Camara Dental Institute
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. At least 18 years old 2. Have healed edentulous sites on the posterior maxillae region with at least 3 months postextraction period 3. Need to receive at least two dental implants 4. Have sufficient residual bone volume for implant placement without the need for bone augmentation where the minimum ridge height and width should be =8 and =6 mm, respectively

Exclusion criteria

Exclusion criteria: 1. Alcoholism 2. Smoking 3. Drug abuse 4. Diabetes 5. Heart disease 6. Bleeding disorders 7. Weakened immune systems 8. Radiation exposure 9. Past or ongoing use of steroids or bisphosphonates 10. Previous bone regenerative or augmentation procedures

Design outcomes

Primary

MeasureTime frame
Insertion torque was measured at T1 using a manual torque wrench (Straumann®) and the implant stability quotient (ISQ) was registered as the average of the buccal, lingual, mesial and distal readings using the Osstell® ISQ device (Osstell, W&H, Gothenburg, Sweden)

Secondary

MeasureTime frame
ISQ measured using the Osstell® ISQ device at 6 months and 1 year after surgery

Countries

Portugal

Contacts

Public ContactMarco Camara
marco.camara@iucs.cespu.pt+351 (0)914112775

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026